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Abstract
Background: Rapid diagnostic tests (RDTs) detecting histidine-rich protein 2 (PfHRP2) antigen are used to identify
individuals with Plasmodium falciparum infection even in low transmission settings seeking to achieve elimination.
However, these RDTs lack sensitivity to detect low-density infections, produce false negatives for P. falciparum
strains lacking pfhrp2 gene and do not detect species other than P. falciparum.
Methods: Results of a PfHRP2-based RDT and Plasmodium nested PCR were compared in a region of declining
malaria transmission in southern Zambia using samples from community-based, cross-sectional surveys from 2008
to 2012. Participants were tested with a PfHRP2-based RDT and a finger prick blood sample was spotted onto filter
paper for PCR analysis and used to prepare blood smears for microscopy. Species-specific, real-time, quantitative
PCR (q-PCR) was performed on samples that tested positive either by microscopy, RDT or nested PCR.
Results: Of 3,292 total participants enrolled, 12 (0.4%) tested positive by microscopy and 42 (1.3%) by RDT. Of 3,213
(98%) samples tested by nested PCR, 57 (1.8%) were positive, resulting in 87 participants positive by at least one of
the three tests. Of these, 61 tested positive for P. falciparum by q-PCR with copy numbers ≤ 2 x 103 copies/μL, 5
were positive for both P. falciparum and Plasmodium malariae and 2 were positive for P. malariae alone. RDT
detected 32 (53%) of P. falciparum positives, failing to detect three of the dual infections with P. malariae. Among
2,975 participants enrolled during a low transmission period between 2009 and 2012, sensitivity of the PfHRP2-based
RDT compared to nested PCR was only 17%, with specificity of >99%. The pfhrp gene was detected in 80% of P.
falciparum positives; however, comparison of copy number between RDT negative and RDT positive samples
suggested that RDT negatives resulted from low parasitaemia and not pfhrp2 gene deletion.
Conclusions: Low-density P. falciparum infections not identified by currently used PfHRP2-based RDTs and the inability
to detect non-falciparum malaria will hinder progress to further reduce malaria in low transmission settings of Zambia.
More sensitive and specific diagnostic tests will likely be necessary to identify parasite reservoirs and achieve malaria
elimination.
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Background
A substantial reduction in the burden of malaria has
been achieved in several countries of sub-Saharan Africa
[1]. Sustaining this level of malaria control and progressing towards elimination will depend on sensitive and
specific diagnostic tools to identify persistent reservoirs
of infection. Although microscopy remains the diagnostic gold standard, malaria rapid diagnostic tests (RDTs)
are widely used throughout malaria endemic areas, particularly in rural settings where access to health facilities
with trained microscopists is limited. As transmission
declines, detection of infected individuals is critical to
achieving and sustaining control. Evaluation of RDT performance in regions of low transmission is necessary.
Zambia has recorded a significant decrease in parasite
prevalence as documented by malaria indicator surveys,
with parasite prevalence among children younger than
five years of age decreasing from 21.8% in 2006 to 14.9%
in 2012 [2]. Southern Province, Zambia reported a parasite prevalence of less than 10% and is considered a potential area for malaria elimination. RDTs based on
detecting histidine-rich protein 2 (PfHRP2), an antigen
produced only by Plasmodium falciparum, have been
used in Zambia since their national introduction in 2009
[3]. However, RDTs lack the sensitivity to detect lowdensity infections compared to more sensitive molecular
methods such as polymerase chain reaction (PCR) [4-6].
Furthermore, P. falciparum parasites with a deletion of
the pfhrp2 gene can cause patent bloodstream infection
but false negative RDT results [7-11]. Identification of
other human malaria parasite species is not possible
with PfHRP2-based RDTs and non-falciparum malaria
may become more apparent as transmission decreases.
To assess the validity of PfHRP2-based RDTs in a hypoendemic area moving towards elimination, results of a
PfHRP2-based RDT were compared to those of a Plasmodium nested PCR. Using real-time, quantitative PCR
(q-PCR), identification of parasite species, quantification
of parasitaemia and potential pfhrp gene deletions were
assessed. This is the first study to examine the presence of
non-P.falciparum species and pfhrp gene deletion in
southern Zambia and the findings have implications for
RDT-based strategies to achieve malaria elimination in
this region.
Methods
The study consisted of community-based, cross-sectional
surveys conducted in the catchment area of Macha
Hospital located in Choma District, Southern Province,
Zambia between 2008 and 2012. Macha Hospital is located approximately 70 km from the nearest town of
Choma on a plateau at an altitude of approximately 1,100
metres above sea level and in a habitat characterised as
Miombo woodland. There is a single rainy season from
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approximately November through April, followed by a
cool, dry season from April to August and a hot, dry season from August to November. The catchment area is
populated by traditional villagers living in small scattered
homesteads. Anopheles arabiensis is the primary vector responsible for malaria transmission [12], which peaks during the rainy season. The Southern Province of Zambia
historically had hyperendemic P. falciparum transmission
but the parasite prevalence and number of hospitalizations
for malaria declined dramatically over the past decade [13].
Cross-sectional surveys were conducted every other
month beginning February 2008. Household and participant selection was as described previously [14], but in
brief, households were randomly selected from satellite
images and all household residents were eligible to participate. Informed consent was obtained from participating adults and from parents or guardians of children
younger than 16 years. Questionnaires were administered to collect information on age, sex and history of
recent malaria and treatment. Finger prick blood samples were used to prepare thick and thin blood smears
for microscopy, RDT (ICT Diagnostics, Cape Town,
South Africa) and spotted onto filter paper (Whatman
903™ Protein Saver card) as dried blood spots (DBS).
The ICT Diagnostics RDT detects PfHRP2 antigen.
Blood smear and DBS samples were transported to a
molecular laboratory at Macha Research Trust, located
within the study area, where both microscopy and Plasmodium nested PCR analysis were performed. Storage of
DBS was at −20°C, with each filter paper card individually sealed in a plastic bag containing desiccant prior to
nucleic acid extraction and PCR analysis. DBS collected
from February to September 2008 were initially stored at
room temperature (within individually sealed plastic
bags with desiccant) but subsequently stored at −20°C.
Microscopic examination was performed at the Macha
Research Trust laboratory within approximately three
days of sample collection. Thin blood smears were airdried, fixed with methanol and Giemsa-stained whereas
thick blood smears were air dried and then Giemsastained without fixing with methanol. Parasitological
diagnosis was made independently by two microscopists,
with discrepancies resolved by a third reader. Parasite
count was recorded per 1,000 white blood cells.
All laboratory assays except q-PCR were performed
at the Macha Research Trust laboratory in Zambia. A
Chelex© extraction method was used to recover parasite
DNA from dried blood spots [15] within approximately
one year of sample collection for DBS collected from
2010 to 2012 and approximately three to five years for
DBS collected in 2008 and 2009. Positive and negative
control samples spotted as dried blood on filter paper
were included in each extraction experiment. Positive
controls consisted of parasitized blood from laboratory
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cultures at 1,000 parasites/μL. Negative controls consisted of blood from individuals with no travel history to
malaria endemic areas. The dried blood spots were
placed in 1.5 mL microcentrifuge tubes, 1 mL of 0.1%
weight by volume saponin in 1x phosphate buffered saline (PBS) was added and the mixture was incubated for
10 minutes at room temperature. The tubes were centrifuged for two minutes at 14,000 rpm, the supernatant
discarded and 1 mL of 1 × PBS was added. The tubes
were again centrifuged for 2 minutes at 14,000 rpm, the
supernatant discarded and 150 μL of 2% weight by volume Chelex© solution and 50 μl of DNase free water
were added and the tubes boiled for 8 minutes.
The tubes were then centrifuged for one minute at
14,000 rpm and approximately 150 μL of DNA was
stored at −20°C.
A Plasmodium nested PCR assay was performed
within approximately one month following the DNA extraction for detection of asexual stage parasite DNA using
two sets of primers targeting a segment of the mitochondrial cytochrome b gene (cytb) conserved in the four
major human Plasmodium parasites [16]. In the primary
PCR step, 6 μL of DNA extract was pipetted into 0.2 mL
tubes containing a 19 μL reaction mix made up of DNase
free water and final concentrations of dNTPs, 10× PCR
buffer, magnesium chloride, forward and reverse primers
and DNA Taq polymerase as 0.2 mΜ, 1×, 3 mΜ, 1 μΜ
and 2 units in 25 μL reaction mix, respectively. In the
nested PCR step, 3 μL of the primary PCR product was
added to 0.2 mL PCR tubes containing 22 μL of reaction
mix containing DNase free water and final concentrations
of dNTPs, 10× buffer, magnesium chloride, forward and
reverse primers and Taq DNA polymerase as 0.2 mΜ, 1×,
2.5 mΜ, 1 μΜ and 2 units in 25 μL reaction mix, respectively. No-template controls were included in each experiment and reactions were run in a Techne™ TC-412
thermo cycler (See Additional file 1). Amplified product
was detected by electrophoresis on 1% agarose gel and
viewed under UV light as an 815 base pair DNA band.
DNA extracts from individuals positive by either microscopy, RDT or nested PCR were shipped with ice
packs to the United States and stored at −20°C prior to
further analyses by q-PCR. P. falciparum, P. malariae
and pfhrp gene detection by q-PCR using specific primer
sets was performed at the Johns Hopkins Bloomberg
School of Public Health between July and October 2013.
Amplification was demonstrated to require ten-fold
dilution with nuclease free water to minimize inhibition
of the q-PCR reaction due to substrate in the crude
Chelex DNA extract. Primers for species-specific cytb
were used to detect P. falciparum and P. malariae. The
primers used for the detection of the pfhrp gene were
designed to amplify the highly conserved secretary
leader of pfhrp as previously reported [17]. The primer

Page 3 of 7

was designed to confirm the presence of pfhrp2 or
pfhrp3 in a single reaction, with expected product sizes
of 278 base pairs and 259 base pairs for pfhrp2 and
pfhrp3, respectively (See Additional file 1). Five μL of reaction mix containing 5 μL of 2x iQ™ SYBR® Green
supermix (Bio-Rad) and 400 nΜ primer were added in
duplicate to a 384-well plate along with 5 μL of ten-fold
diluted DNA extract. Standards were generated by serial
dilution of genomic DNA. Ten-fold dilutions of
laboratory-cultured 3D7 genomic DNA were used as
standards for P. falciparum and pfhrp gene detection
(See Additional file 2), whereas P. malariae genomic
DNA from a single infected individual was used as a
standard for detection of P. malariae. The loaded plates
were centrifuged for 5 minutes at 2,000 rpm and reactions were run in a Bio-Rad CFX384™ real time thermo
cycler. Baseline thresholds were uniform for all experiments of the same assay and cycle count values falling
within the range set by the standards were used to determine positive results for each q-PCR assay. Absolute
quantification was used to determine gene copy numbers for the P. falciparum and pfhrp q-PCR assays based
on the standard curve generated from the 3D7 dilutions
(See Additional file 3).

Results
A total of 3,292 study participants were enrolled from
2008 through 2012 (See Additional file 4). Of these
3,292 participants, 12 (0.4%) were positive by microscopy and 42 (1.3%) were positive by PfHRP2-based RDT.
Nested PCR was performed on 3,213 (98%) samples and
57 (1.8%) positive individuals were identified. In 2008,
nested PCR was performed on 276 (87%) of the 317
samples collected; however, the prevalence of nested
PCR positivity (3.6%) was lower than RDT positivity
(10%) presumably as a consequence of long storage time.
Hence, results from 2008 were not included in the comparisons between RDT and nested PCR as potential
nested PCR positive but RDT and microscopy negative
samples may have been missed. Consequently, 2,975
samples were used for comparison of RDT and nested
PCR for the study period 2009 to 2012.
Parasite prevalence by microscopy, RDT and nested PCR
from 2009 to 2012

Of the 2,975 participants enrolled in the cross sectional
surveys during the four-year period of low transmission
from 2009 through 2012, only four individuals were
positive for malaria by microscopy (0.13%) and ten by
RDT (0.34%). Of the 2,937 (99%) samples tested by
nested PCR, 47 were positive (1.6%). The parasite prevalence by RDT was 0.74% in 2009, 0.23% in 2010, 0.4% in
2011 and 0% in 2012, whereas the parasite prevalence by
nested PCR was 2.7% in 2009, 1.8% in 2010, 1.5% in
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2011 and 0.44% in 2012 (Figure 1). The sensitivity of the
PfHRP2-based RDT compared to the nested PCR was
only 17% (Table 1). In this study setting in which all
household residents were tested regardless of symptoms,
in contrast to a clinical setting where the prevalence of
malaria would be higher, the positive predictive value of
the RDT compared to nested PCR was 80%, with a negative predictive value of 99%.
Identification of Plasmodium species

The q-PCR for P. falciparum and P. malariae was performed on 49 samples collected from 2009 through 2012
that were positive for malaria by RDT, microscopy or
nested PCR as well as an additional 38 samples collected
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during 2008 and positive by at least one of the three
tests, yielding a total of 87 samples on which q-PCR was
performed.
Of these 87 samples, 56 (64%) were positive by q-PCR
for P. falciparum alone, five were positive for both P. falciparum and P. malariae and two were positive for P.
malariae alone (Table 2). Thus, 61 (70%) were positive
for P. falciparum and seven for P. malariae (0.2% of all
participants). The q-PCR was negative for 24 individuals
who tested positive by either microscopy, RDT or nested
PCR. Of these 24, one was positive by microscopy only,
eight were positive by RDT only, thirteen were positive
by nested PCR only, and two were positive by both RDT
and nested PCR.

Figure 1 Parasite prevalence as measured by microscopy, PfHRP2-RDT and Plasmodium nested PCR. Prevalence by microscopy and ICT
Diagnostics RDT per year on a total of 3, 292 participants and by nested PCR on 3,213 (98%) participants enrolled between 2008 and 2012. *PCR
data for 2008 excluded.
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Table 1 Comparison of PfHRP2-based RDT results with microscopy and nested PCR from 2009 – 2012
Microscopy positive

Microscopy negative

Total

PCR positive

PCR negative

Total

RDT positive

2

8

10

8

2

10

RDT negative

2

3280

3282

39

2888

2927

Total

4

3288

3292

47

2890

2937*

*Of the 2,975 enrolled during this period, 2,937 (99%) were tested by both RDT and nested PCR.
Sensitivity of PfHRP2-based RDT compared to microscopy = 0.50.
Specificity of PfHRP2-based RDT compared to microscopy = > 0.99.
Positive predictive value of PfHRP2-based RDT compared to microscopy = 20%.
Negative predictive value of PfHRP2-based RDT compared to microscopy = > 99%.
Sensitivity of PfHRP2-based RDT compared to PCR = 0.17.
Specificity of PfHRP2-based RDT compared to PCR = > 0.99.
Positive predictive value of PfHRP2-based RDT compared to PCR = 80%.
Negative predictive value of PfHRP2-based RDT compared to PCR = 99%.

Of the 42 individuals positive by RDT from 2008
through 2012, 32 were positive for P. falciparum by qPCR. Eight of the 10 individuals positive by RDT but
negative by q-PCR were also negative by microscopy and
nested PCR, suggesting these individuals had persistent
PfHRP2 antigenaemia in the absence of visible parasites
or parasite DNA. Only one of these eight individuals reported prior treatment, but with an herbal medicine and
not artemisinin combination therapy. The remaining
two samples were positive by nested PCR, which suggested either false positive results for both RDT and
nested PCR or false negative q-PCR. Of the 12 individuals positive by microscopy, only one was negative by qPCR, suggestive of either false positive microscopy or
false negative q-PCR.
Quantification of P. falciparum parasitaemia

The P. falciparum genome size is 23 mega bases [18] and
on the assumption that the average weight of one mole of
a base pair is 650 g, 1 ng of parasite genomic DNA corresponds to 40,000 copies of the target gene. The limit of
detection for P. falciparum q-PCR was determined to be
0.04 copies/μL. The cytb gene copy numbers quantified by
q-PCR for the 61 samples positive for P. falciparum
ranged from 1 × 10−1 copies/μL to 2 × 103 copies/μL. The
mean copy number for individuals positive by both RDT
and P. falciparum cytb q-PCR was 97 copies/μL (range
0.05 to 2178 copies/μL, SD = 381) in contrast to a mean
Table 2 Plasmodium species identification by q-PCR
P. falciparum P. malariae P. falciparum
and P. malariae
Total positive by
q-PCR*

56

2

5

Also positive by
microscopy

10

0

1

Also positive by RDT

30

0

2

Also positive by nested
PCR

37

2

3

copy number of 8 copies/μL (range 0.1 to 96 copies/μL,
SD = 18) for individuals who were RDT negative but P.
falciparum q-PCR positive (Table 3).
Detection of pfhrp gene in P. falciparum infections

The limit of detection for the pfhrp gene by q-PCR was
4 copies/μL. The pfhrp gene was present in 49 (80%) of
the 61 samples confirmed to have P. falciparum DNA by
q-PCR. Of the 32 samples positive by both RDT and qPCR, the pfhrp gene was detectable in 26 (81%). Of the
29 RDT-negative but q-PCR positive samples for P. falciparum, the pfhrp gene was detected in 23 (79%). The
mean copy number of Pfcytb q-PCR was approximately
13-fold lower among RDT negative samples compared
to RDT positive samples. Similarly, the mean pfhrp copy
number was approximately 7-fold lower among RDT
negative samples compared to RDT positive samples
(Table 3).

Discussion
In a region of declining malaria transmission in southern
Zambia, a PfHRP2-based RDT had low sensitivity in detecting P. falciparum infections and failed to detect a
small number of mixed infections with P. malariae. Failure to detect the pfhrp gene in approximately 20% of infections with P. falciparum was likely a consequence of
low parasite density rather than deletion of the pfhrp
gene. Although the absolute prevalence of malaria was
low, PCR detected four to nine times the number of infections than the PfHRP2-based RDT.
Table 3 Pfcytb and Pfhrp copy numbers in individuals
positive for P. falciparum by q-PCR
P. falciparum Pfhrp
q-PCR
q-PCR
positive
result (N)
RDT positive

*Of the 87 tested samples that were positive by RDT, microscopy or PCR, 24
were negative by q-PCR.

32

RDT negative 29

NA = not amplified.

Pfcytb
Pfhrp
mean copy mean copy
number/μL number/μL

positive (26) 97

1827

negative (6)

NA

positive (23) 8

237

negative (6)

NA
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Field evaluations of PfHRP2-based RDTs have reported
high sensitivities in medium to high malaria transmission
settings [19,20] where parasite densities commonly exceed
200 parasite/μL. However, recent studies conducted in
pre-elimination settings in sub-Saharan Africa have shown
a reduction in sensitivity of RDTs for malaria detection.
The sensitivity of RDT compared to PCR in Zanzibar was
76.5% [21], higher than observed in Zambia. In regions of
declining transmission, this may reflect low-level parasitaemia in individuals with clinical immunity acquired when
transmission was higher. Incorporation of more sensitive
diagnostics may be necessary in such settings to eliminate
the residual infectious reservoir, consistent with recent
recommendations by the WHO Malaria Policy Advisory
Committee on the role of nucleic acid-based malaria diagnosis in low transmission settings [22]. If transmission remains low for an extended period, clinical immunity may
be lost, resulting in more frequent symptomatic infections
with higher levels of parasitaemia and increased sensitivity
of RDTs.
Non-falciparum Plasmodium species have previously
been described in Zambia although they constitute a
small proportion of infections. Infection with Plasmodium ovale was described in the 1960’s [23] and infection with P. malariae was estimated to comprise 2-4% of
malaria infections in Zambia. In 2012, the prevalence of
infection with P. malariae was 2.1% in Nchelenge District in northern Zambia [24].
Although P. falciparum not expressing PfHRP2 has
been reported from some regions [25], the pfhrp2 gene
was present in the majority of the circulating P. falciparum parasites in southern Zambia. This is the first report of prevalence of pfhrp2 in circulating P. falciparum
parasites in Zambia and continued monitoring for the
occurrence of pfhrp gene deletions will be necessary as
PfHRP2-based RDTs continue to be used.

Conclusions
Current efforts to achieve malaria elimination in southern Zambia using reactive case detection based on RDTs
may be insufficiently sensitive to interrupt transmission.
Alternative strategies, such as focal drug administration
or the use of more sensitive and specific diagnostic tests,
may be necessary to eliminate the parasite reservoir.
Additional files
Additional file 1: Primer sequences and reaction conditions for PCR
assays. Amplification of asexual-stage Plasmodium parasite used primers
targeting a region of the mitochondrial cytochrome b (cytb) gene
conserved in the four major human malaria parasites. Identification of
species and detection of pfhrp gene were based on species-specific cytb
primers and primers amplifying a highly conserved secretary leader of
the pfhrp gene respectively.
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Additional file 2: Amplification curve for Plasmodium falciparum
q-PCR. Q-PCR amplification curve for P. falciparum detection was
generated by Bio-Rad CFX-384 Thermocycler using ten-fold dilutions of
3D7 genomic DNA from a 1 nanogram stock.
Additional file 3: Standard curve for absolute quantification of
Plasmodium falciparum parasitaemia. Quantification was based on 1
nanogram of P. falciparum genomic DNA corresponding to 40,000 target
gene copy number.
Additional file 4: Number of samples tested by Microscopy, RDT,
nested PCR and the q-PCR per study year.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NL carried out the molecular analysis, analysed data and drafted the
manuscript. TK and DS analysed data and reviewed the manuscript. HH
coordinated field sample collection. SM and PET supervised field and
laboratory data collection. CS obtained Fogarty Training Grant funding and
reviewed the manuscript. WJM set up the project, participated in study
design and drafted the manuscript. All authors read and approved the
manuscript.
Acknowledgements
NL gratefully acknowledges Fogarty Training Grant (7D43TW001587-08)
awarded to Dr. Nirbhay Kumar which funded her work in the laboratory of
Dr. David Sullivan at The Johns Hopkins Bloomberg School of Public Health.
This work was supported by the Johns Hopkins Malaria Research Institute,
the Bloomberg Family Foundation and the Division of Microbiology and
Infectious Diseases, National Institutes of Allergies and Infectious Diseases,
National Institutes of Health as part of the International Centers of Excellence
for Malaria Research (U19 AI089680). Thanks are also due to the field team
and laboratory staff at Macha Research Trust and most importantly to
participants from the Macha community who provided the data for this
study.
Author details
1
Macha Research Trust, Choma, Zambia. 2Department of Epidemiology,
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3W.
Harry Feinstone Department of Molecular Microbiology and Immunology,
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Received: 19 August 2014 Accepted: 5 January 2015

References
1. O’Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden
of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10:545–55.
2. Government of the Republic of Zambia MoH. Zambia National Malaria
Indicator Survey 2012. 2013.
3. Yukich JO, Bennett A, Albertini A, Incardona S, Moonga H, Chisha Z, et al.
Reductions in artemisinin-based combination therapy consumption after
the nationwide scale up of routine malaria rapid diagnostic testing in
Zambia. Am J Trop Med Hyg. 2012;87:437–46.
4. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, et al. A
large proportion of asymptomatic Plasmodium infections with low and
sub-microscopic parasite densities in the low transmission setting of
Temotu Province, Solomon Islands: challenges for malaria diagnostics in
an elimination setting. Malar J. 2010;9:254.
5. Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. Detection of a substantial
number of sub-microscopic Plasmodium falciparum infections by polymerase
chain reaction: a potential threat to malaria control and diagnosis in Ethiopia.
Malar J. 2013;12:352.
6. McMorrow ML, Aidoo M, Kachur SP. Malaria rapid diagnostic tests in
elimination settings–can they find the last parasite? Clin Microbiol Infect.
2011;17:1624–31.
7. Koita OA, Doumbo OK, Ouattara A, Tall LK, Konare A, Diakite M, et al.
False-negative rapid diagnostic tests for malaria and deletion of the
histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg.
2012;86:194–8.

Laban et al. Malaria Journal (2015) 14:25

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.
23.
24.

25.

Page 7 of 7

Kumar N, Pande V, Bhatt RM, Shah NK, Mishra N, Srivastava B, et al. Genetic
deletion of HRP2 and HRP3 in Indian Plasmodium falciparum population
and false negative malaria rapid diagnostic test. Acta Trop. 2013;125:119–21.
Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, et al. Rapid
diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of
pfhrp2 gene deletions and cross-reactions. PLoS One. 2012;7:e43094.
Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, et al. A
large proportion of P. falciparum isolates in the Amazon region of Peru lack
pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One.
2010;5:e8091.
Houze S, Hubert V, Le Pessec G, Le Bras J, Clain J. Combined deletions
of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria
false-negative rapid diagnostic test. J Clin Microbiol. 2011;49:2694–6.
Kent RJ, Thuma PE, Mharakurwa S, Norris DE. Seasonality, blood feeding
behavior, and transmission of Plasmodium falciparum by Anopheles
arabiensis after an extended drought in southern Zambia. Am J Trop Med
Hyg. 2007;76:267–74.
Moss WJ, Norris DE, Mharakurwa S, Scott A, Mulenga M, Mason PR, et al.
Challenges and prospects for malaria elimination in the Southern Africa
region. Acta Trop. 2012;121:207–11.
Sutcliffe CG, Kobayashi T, Hamapumbu H, Shields T, Kamanga A, Mharakurwa S,
et al. Changing individual-level risk factors for malaria with declining
transmission in southern Zambia: a cross-sectional study. Malar J.
2011;10:324.
Kain KC, Lanar DE. Determination of genetic variation within Plasmodium
falciparum by using enzymatically amplified DNA from filter paper disks
impregnated with whole blood. J Clin Microbiol. 1991;29:1171–4.
Steenkeste N, Incardona S, Chy S, Duval L, Ekala MT, Lim P, et al. Towards
high-throughput molecular detection of Plasmodium: new approaches and
molecular markers. Malar J. 2009;8:86.
Sullivan Jr DJ, Ayala YM, Goldberg DE. An unexpected 5’ untranslated intron
in the P. falciparum genes for histidine-rich proteins II and III. Mol Biochem
Parasitol. 1996;83:247–51.
Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al. Genome
sequence of the human malaria parasite Plasmodium falciparum. Nature.
2002;419:498–511.
Moonasar D, Goga AE, Kruger PS, La Cock C, Maharaj R, Frean J, et al. Field
evaluation of a malaria rapid diagnostic test (ICT Pf). S Afr Med J.
2009;99:810–3.
Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dorsey G.
Rapid diagnostic tests for malaria at sites of varying transmission intensity in
Uganda. J Infect Dis. 2008;197:510–8.
Shakely D, Elfving K, Aydin-Schmidt B, Msellem MI, Morris U, Omar R, et al.
The usefulness of rapid diagnostic tests in the new context of low malaria
transmission in Zanzibar. PLoS One. 2013;8:e72912.
WHO. Recommendation for malaria diagnostics in low transmission settings.
Geneva: World Health Organization; 2014.
Wolfe HL. Plasmodium ovale in Zambia. Bull World Health Organ.
1968;39:947–8.
Nambozi M, Malunga P, Mulenga M, Van Geertruyden JP, D’Alessandro U.
Defining the malaria burden in Nchelenge District, northern Zambia using
the World Health Organization malaria indicators survey. Malar J.
2014;13:220.
Cheng Q, Gatton ML, Barnwell J, Chiodini P, McCarthy J, Bell D, et al.
Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3:
a review and recommendations for accurate reporting. Malar J. 2014;13:283.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

